PHS
NVRO

PFM Health Sciences’s NEVRO CORP. NVRO Stock Holding History

PFM Health Sciences’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-563,560
Closed -$26.3M – 101
2022
Q3 		$26.3M Sell
563,560
-95,850
-15% -$4.45M 0.95% 48
2022
Q2 		$28.9M Buy
659,410
+9,897
+2% +$544K 1.1% 41
2022
Q1 		$47M Buy
649,513
+164,378
+34% +$11.9M 1.76% 22
2021
Q4 		$39.3M Buy
485,135
+92,349
+24% +$9.25M 1.34% 39
2021
Q3 		$45.7M Sell
392,786
-25,859
-6% -$3.38M 1.34% 33
2021
Q2 		$69.4M Sell
418,645
-26,232
-6% -$4.09M 2.18% 15
2021
Q1 		$62.1M Buy
444,877
+132,937
+43% +$21.7M 1.9% 16
2020
Q4 		$54M Sell
311,940
-6,292
-2% -$1.02M 1.9% 16
2020
Q3 		$44.3M Buy
318,232
+214,052
+205% +$28.6M 2.05% 12
2020
Q2 		$12.4M Buy
+104,180
New +$12.4M 0.65% 53
2020
Q1 		– Sell
-577,163
Closed -$67.8M – 80
2019
Q4 		$67.8M Buy
577,163
+180,893
+46% +$17.9M 3.23% 7
2019
Q3 		$34.1M Sell
396,270
-434,564
-52% -$32.9M 1.01% 38
2019
Q2 		$53.9M Buy
830,834
+109,605
+15% +$6.82M 1.02% 35
2019
Q1 		$45.1M Buy
721,229
+165,134
+30% +$7.77M 1% 35
2018
Q4 		$21.6M Buy
+556,095
New +$24.7M 0.57% 56
2017
Q2 		– Sell
-116,836
Closed -$10.9M – 117
2017
Q1 		$10.9M Buy
+116,836
New +$10.6M 0.27% 83

Other funds holding NVRO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PFM Health Sciences's NVRO Position: Q4 2022 in Review

PFM Health Sciences sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 563,560 shares — an estimated $26.3M sold.

PFM Health Sciences first reported a position in NVRO in Q1 2017 and held it in 16 quarters. The position peaked at $69.4M in Q2 2021. 170 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

  • PFM Health Sciences reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
  • PFM Health Sciences sold 563,560 NEVRO CORP. shares in Q4 2022, an estimated $26.3M.
  • PFM Health Sciences first reported a position in NEVRO CORP. in Q1 2017 and held it in 16 quarters.
  • PFM Health Sciences's NEVRO CORP. position peaked at $69.4M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on PFM Health Sciences's 13F filing for Q4 2022, filed 14 Feb 2023.